| Original language | English |
|---|---|
| Pages (from-to) | e17-e21 |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 81 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - May 1 2019 |
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)
Cite this
The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis : Findings From a Randomized Study. / for GUSTA trial study group.
In: Journal of acquired immune deficiency syndromes (1999), Vol. 81, No. 1, 01.05.2019, p. e17-e21.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis
T2 - Findings From a Randomized Study
AU - for GUSTA trial study group
AU - Rossetti, Barbara
AU - Gagliardini, Roberta
AU - Sterrantino, Gaetana
AU - Colangeli, Vincenzo
AU - Latini, Alessandra
AU - Colafigli, Manuela
AU - Vignale, Francesca
AU - Rusconi, Stefano
AU - Di Biagio, Antonio
AU - Orofino, Giancarlo
AU - Mezzaroma, Ivano
AU - Vullo, Vincenzo
AU - Francisci, Daniela
AU - Mastroianni, Claudio
AU - Trezzi, Michele
AU - Canovari, Benedetta
AU - Lamonica, Silvia
AU - Ciccullo, Arturo
AU - Borghetti, Alberto
AU - DʼArminio Monforte, Antonella
AU - Di Giambenedetto, Simona
AU - De Luca, Andrea
PY - 2019/5/1
Y1 - 2019/5/1
UR - http://www.scopus.com/inward/record.url?scp=85064722385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064722385&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001986
DO - 10.1097/QAI.0000000000001986
M3 - Article
C2 - 30789452
AN - SCOPUS:85064722385
VL - 81
SP - e17-e21
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
SN - 1525-4135
IS - 1
ER -